Public Company Management Corporation is a development stage company. The Company's business plan is to seek new business opportunities or to engage in a merger or acquisition with an unidentified company. The Companyâ€™s operations have been limited to seeking a potential business combination and has had no revenue from operations.

Employees

Sector

Investment Holding Companies

More about the company

Market Closed - OTC Markets 09:55:18 13/05/2026 pm IST			5-day change	1st Jan Change
0.4490 ^USD	+36.06%		+79.60%	+113.81%

05/08	Public Company Management Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2026	CI
12/05	Public Company Management Corp. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2026	CI

Market Cap	85.69L 74.25L 70.07L 63.57L 1.19Cr 82Cr 1.2Cr 8.37Cr 3.22Cr 42Cr 3.22Cr 3.15Cr 132.46Cr	P/E 2024	-89.4x	P/E 2025	-132x
Enterprise Value	86.85L 75.25L 71.02L 64.43L 1.21Cr 83Cr 1.22Cr 8.48Cr 3.27Cr 42Cr 3.26Cr 3.19Cr 134.25Cr	EV / Sales 2024	-	EV / Sales 2025	-
Free-Float	30.14%	Yield 2024 *	-	Yield 2025	-

05/08	Public Company Management Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2026	CI
12/05	Public Company Management Corp. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2026	CI
25/02	Public Company Management Corp. entered into a non-binding letter of intent to acquire Physicians Capital Management Corporation from Conrad Ivie, M.D.	CI
18/02	Public Company Management Corp. Reports Earnings Results for the First Quarter Ended December 31, 2025	CI
05/02	Public Company Management Corp. Reports Earnings Results for the Full Year Ended September 30, 2025	CI
04/02	Public Company Management Corp. Auditor Raises 'Going Concern' Doubt	CI
14/25/14	Public Company Management Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2025	CI
09/25/09	Public Company Management Corp. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2025	CI
12/25/12	Public Company Management Corp. Reports Earnings Results for the First Quarter Ended December 31, 2024	CI
13/25/13	Public Company Management Corp. Reports Earnings Results for the Full Year Ended September 30, 2024	CI
13/25/13	Public Company Management Corp. Auditor Raises 'Going Concern' Doubt	CI
09/24/09	Public Company Management Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2024	CI
10/24/10	Public Company Management Corp. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	CI

05/02	Public Management : Annual Report for Fiscal Year Ending September 30, 2025 (Form 10-K)	PU
13/25/13	Public Management : Annual Report for Fiscal Year Ending September 30, 2024 (Form 10-K)	PU
03/23/03	Public Management : Change in Certifying Accountants - Form 8-K	PU
13/23/13	PUBLIC CO MANAGEMENT CORP : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Change in Directors or Principal Officers, Other Events (form 8-K)	AQ
06/23/06	PUBLIC CO MANAGEMENT CORP : Change in Directors or Principal Officers (form 8-K)	AQ

Public Company Management Corp. Share Price

Stocks

PCMC

US7443921017

Investment Holding Companies

Valuation: Public Company Management Corp.

Chart: Public Company Management Corp.

Latest news: Public Company Management Corp.

Press Releases: Public Company Management Corp.

Quotes and Performance

Price Extremes

Managers and Directors: Public Company Management Corp.

Shell Companies

Financials

Company Profile

1 day	+36.06%
1 week	+79.60%
Current month	+79.60%
1 month	+36.06%
3 months	+9.51%
6 months	+21.35%
Current year	+113.81%

1 month	0.25	0.45
Current year	0.21	0.47
1 year	0.21	0.49
3 years	0.05	0.68
5 years	0	0.68
10 years	0	0.68

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
PUBLIC COMPANY MANAGEMENT CORP.	+36.06%	+79.60%	+12.25%	+461.95%	85.69L
CHURCHILL CAPITAL CORP XI	-2.60%	-10.45%	-	-	67Cr
DRUGS MADE IN AMERICA ACQUISITION II CORP.	+0.17%	+0.10%	-	-	65Cr
BAIN CAPITAL GSS INVESTMENT CORP.	+0.10%	-0.15%	-	-	60Cr
CANTOR EQUITY PARTNERS IV, INC.	+0.10%	-0.34%	+2.02%	-	59Cr
CENTIEL AG	+1.42%	-3.70%	+248.78%	-77.12%	56Cr
AMERICAN EXCEPTIONALISM ACQUISITION CORP. A	-0.88%	-1.84%	-	-	55Cr
NEW AMERICA ACQUISITION I CORP.	+0.05%	-0.20%	-	-	50Cr
ARES ACQUISITION CORPORATION III	-0.20%	+0.40%	-	-	50Cr
Average	+3.86%	-1.69%	+87.68%	+192.42%	51.55Cr
Weighted average by Cap.	-0.14%	-2.09%	+121.43%	-69.04%

	2024	2025
Net sales	-	-
Net income	-75.52T -65.44T -61.75T -56.02T -1L -72.38L -1L -7L -3L -36.72L -3L -3L -1.17Cr	-1L -89.96T -84.89T -77.02T -1L -99.5L -1L -10.14L -4L -50.48L -4L -4L -1.6Cr
Net Debt	4L 4L 3L 3L 6L 4.07Cr 6L 41.5L 15.99L 2.07Cr 15.96L 15.61L 6.57Cr	1L 1L 94.52T 85.75T 2L 1.11Cr 2L 11.29L 4L 56.21L 4L 4L 1.79Cr